The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; MSD; Novartis; Pfizer; Roche
Association between progression-free survival (PFS) rate (PFSR) and overall survival (OS) in LUME-Meso, a study of nintedanib (N) vs. placebo (P) in combination with first-line pemetrexed/cisplatin (PEM/CIS) in patients (pts) with malignant pleural mesothelioma (MPM).
 
Nick Pavlakis
Honoraria - Bayer; Boehringer Ingelheim; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
 
Federica Grosso
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pharmamar
 
Nicola L. Steele
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD Oncology; Pfizer
 
Anna K. Nowak
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Epizyme; Merck Sharp & Dohme; Roche; Sellas Life Sciences; Trizell
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim
 
Silvia Novello
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Sanjay Popat
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Guardant Health; Lilly; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Epizyme (Inst); Lilly (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Laurent Greillier
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Martin Reck
No Relationships to Disclose
 
Tom John
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Ignyta; MSD Oncology; Novartis; Pfizer; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Boehringer Ingelheim; Ignyta; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Roche
 
Paul Taylor
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Natasha B. Leighl
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
 
Giovanni Luca Ceresoli
Research Funding - Bayer
 
Jens Benn Sørensen
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD; Novartis; Pfizer; Roche
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly/ImClone; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Mark A. Socinski
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - Genentech; Pfizer (Inst)
 
Ute von Wangenheim
Employment - Boehringer Ingelheim
 
Jose Barrueco
Employment - Boehringer Ingelheim
 
Giorgio V. Scagliotti
Honoraria - AstraZeneca; Lilly; MSD; Pfizer; Roche
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly; MSD
Travel, Accommodations, Expenses - Bayer